Table 3.
Adverse event | No. (%) subjects affected | No. (%) possibly related to treatment |
---|---|---|
Constipation | 20 (55.6) | 14 (70) |
Diarrhea | 17 (47.2) | 14 (82.4) |
Injection site reaction | 14 (38.9) | 14 (100) |
Pruritus | 10 (27.8) | 10 (100) |
Rash/desquamation | 9 (25) | 9 (100) |
Fatigue | 18 (50) | 13 (72.2) |
Nausea | 9 (25) | 8 (88.9) |
Dizziness | 9 (25) | 3 (33.3) |
Fever (without neutropenia) | 5 (13.9) | 2 (40) |
Insomnia | 6 (16.7) | 3 (50) |
Dyspepsia | 4 (11.1) | 4 (100) |
Headache | 5 (13.9) | 2 (40) |
Cough | 8 (22.2) | 0 (0) |
Dyspnea | 10 (27.8) | 4 (40) |
Hypotension | 5 (13.9) | 2 (40) |
Constitutional symptoms, other | 6 (16.7) | 4 (66.7) |
Rigors/chills | 4 (11.1) | 1 (25) |
Dermatology/skin, other | 9 (25) | 3 (33.3) |
Anorexia | 6 (16.7) | 3 (50) |
Gastrointestinal, other | 4 (11.1) | 1 (25) |
Dysgeusia | 4 (11.1) | 4 (100) |
Vomiting | 4 (11.1) | 3 (75) |
Edema: limb | 5 (13.9) | 2 (40) |